Congratulations to Prof. Rami Aqeilan and MD-PhD student Daniel Steinberg for their newly published article in EMBO Molecular Medicine!

This study opens a new avenue for studying Developmental and Epileptic Encephalopathies in a human context, providing insight into a hitherto rare topic. Moreover, it serves as a platform to study possible therapeutic intervention, and although further study is required before clinical translation, the data serves as a proof-of-concept for the use of genetic therapy […]

New Review published on Trends in Cell Biology

A fascinating and intriguing review on the putative homeostatic role of cancer mutations is published by Prof. Yinon Ben Neriah, Prof. Eli Pikarsky, and PhD student Avanthika Venkatachalam. In this review the authors discuss the potential constructive role of driver mutations in maintenance of tissue homeostasis, and whether they are linked to augmented stem cell […]

Together with eminent virology colleagues from Italy and Germany, Prof. Dana Wolf organized the European Seminar in Virology.

The exciting program, with leading state-of-the art speakers and students from all over Europe, put an emphasis on SARS-CoV-2. Discussions included neutralizing antibody responses to SARS-CoV-2 variants, vaccines, other viral agents, antiviral vaccine vectors, and vaccine development against SARS-CoV-2. In addition to SARS-CoV-2, other viral infections were also well-represented,  including intrinsic restriction factors to HIV and […]

Congratulations to Prof. Rami Aqeilan and his post-doctoral researcher Dr. Sri Repudi for their new paper published in EMBO Molecular Medicine on the preclinical assessment of WWOX gene therapy as a possible treatment for WOREE syndrome.

“In this study, we showed that a single ICV injection of AAV9-Syn1-WWOX in Wwox-null neonates rescues the phenotypes associated with WWOX deficiency including growth retardation, hypoglycemia, hypomyelination, seizures and premature lethality.” says Prof. Aqeilan. “Additionally, treated mice were fertile and exhibited normal behaviour” he added. This proof-of-concept preclinical assessment provides hope for WOREE and SCAR12 […]

Congratulations to post-doctoral student Dr. Hassan Elsana

Dr. Elsana, a member of Prof. David Naor’s team, who was accepted to Teva’s National Forum for BioInnovators program! He was selected as one of 31 top post-docs from Israeli academic institutions. Included in this program, he will also receive from a grant of $10,000 to support his research. Well done! To Prof. Naor lab